Abstract
The end-stage kidney disease (ESKD) population receiving maintenance dialysis is highly vulnerable to the devastating consequences of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and associated coronavirus disease 2019 (COVID-19). Although uremia itself is associated with an immune-incompetent state, patients with ESKD are generally older and often have comorbid conditions that increase the risk for poor outcomes in COVID-19.1,2 To date, information on the clinical course of COVID-19 among the ESKD population is limited to single-center experiences and/or homogeneous populations.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.